U.S., Oct. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07217483) titled 'The Feasibility of Cream for Treatment of Neonatal Hypoglycemia' on Oct. 12.
Brief Summary: Prolact CR (cream) is a fat supplement that is derived from pasteurized human donor milk. It has been utilized in babies who are born premature in the neonatal intensive care unit (NICU) setting to improve growth while avoiding cow milk exposure. There is no literature on the use of cream as a treatment for low blood glucose levels in newborns who are at risk. It is known that fat in human colostrum plays a vital role in providing energy, substrate, and stimulates gluconeogenesis. Gluconeogenesis is the process that helps in the sustainment o...